- Posts:
- 0 (0 per day)
- Age:
- N/A
- Date Registered:
- May 13, 2024, 08:43:59 AM
- Local Time:
- June 07, 2024, 11:07:19 PM
- Last Active:
- May 13, 2024, 02:29:14 PM
Signature:
Each TACE plus apatinib and TACE along with apatinib in addition camrelizumab had been feasible in patients with unresectable HCC, along with workable